Order Article Reprints

Tozzi M, Sørensen CE, Magni L, Christensen NM, Bouazzi R, Buch CM, Stefanini M, Duranti C, Arcangeli A, Novak I. Proton Pump Inhibitors Reduce Pancreatic Adenocarcinoma Progression by Selectively Targeting H⁺, K⁺-ATPases in Pancreatic Cancer and Stellate Cells. Cancers. 2020; 12(3):640. https://doi.org/10.3390/cancers12030640

Tozzi, Marco, Christiane E. Sørensen, Lara Magni, Nynne M. Christensen, Rayhana Bouazzi, Caroline M. Buch, Matteo Stefanini, Claudia Duranti, Annarosa Arcangeli, and Ivana Novak. 2020. "Proton Pump Inhibitors Reduce Pancreatic Adenocarcinoma Progression by Selectively Targeting H⁺, K⁺-ATPases in Pancreatic Cancer and Stellate Cells" Cancers 12, no. 3: 640. https://doi.org/10.3390/cancers12030640

Tozzi, M., Sørensen, C. E., Magni, L., Christensen, N. M., Bouazzi, R., Buch, C. M., Stefanini, M., Duranti, C., Arcangeli, A., & Novak, I. (2020). Proton Pump Inhibitors Reduce Pancreatic Adenocarcinoma Progression by Selectively Targeting H⁺, K⁺-ATPases in Pancreatic Cancer and Stellate Cells. Cancers, 12(3), 640. https://doi.org/10.3390/cancers12030640